βIIPKC and εPKC isozymes as potential pharmacological targets in cardiac hypertrophy and heart failure.
Ferreira JC, Brum PC, Mochly-Rosen D. (2011) J. Mol. Cell. Cardiol. 51(4):479-84 [PubMed]
Ferreira JC, Brum PC, Mochly-Rosen D. (2011) J. Mol. Cell. Cardiol. 51(4):479-84 [PubMed]